home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Gritstone bio, Inc. - Common Stock (NQ:GRTS)

0.0322 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 21, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gritstone bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

November 08, 2023

From Gritstone bio

Via GlobeNewswire

Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio’s BARDA Award

October 12, 2023

From Genevant Sciences

Via GlobeNewswire

Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine

October 11, 2023

From Gritstone bio

Via GlobeNewswire

Gritstone Bio: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Gritstone Oncology's Return On Capital Employed Overview ↗

March 15, 2023

Via Benzinga

Earnings Outlook For Gritstone Oncology ↗

March 08, 2023

Via Benzinga

Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 06, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 03, 2023

Via Benzinga

Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 28, 2023

Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 28, 2023

Via Benzinga

Why Gritstone bio Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗

September 28, 2023

Gainers Inpixon (NASDAQ: INPX) shares rose 44.6% to $0.2023 in pre-market trading after gaining around 10% on Wednesday.

Via Benzinga

Why Is Vaccine Focused Gritstone bio Stock Trading Higher Today? ↗

September 28, 2023

Gritstone Bio Inc (NASDAQ: GRTS) received a contract from the Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase 2b comparative study evaluating its self-amplifying mRNA...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 28, 2023

We're checking out the biggest pre-market stock movers worth watching on Friday with a dive into all of the latest market stories!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 27, 2023

Via Benzinga

Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million

September 27, 2023

From Gritstone bio

Via GlobeNewswire

Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle ↗

September 05, 2023

Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to be used in EU countries'...

Via Benzinga

Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

August 09, 2023

From Gritstone bio

Via GlobeNewswire

Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates

May 11, 2023

From Gritstone bio

Via GlobeNewswire

Moderna, Merck's Cancer Vaccines Exhibit Positive Outcomes Under Midstage Trial ↗

April 17, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023 ↗

March 28, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 10, 2023

Via Benzinga

Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

March 09, 2023

From Gritstone bio

Via GlobeNewswire

The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks ↗

February 24, 2023

Startling cancer vaccine results from Moderna may point to the next big thing in biotech.

Via Investor's Business Daily

Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket ↗

December 15, 2022

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.

Via Benzinga

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 13, 2022

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

Via Benzinga

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces New Board Member

December 05, 2022

Via Investor Brand Network

Topics Artificial Intelligence Intellectual Property

Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors

December 05, 2022

From Predictive Oncology Inc.

Via GlobeNewswire

Why G Medical Innovations Shares Are Trading Lower By 35%; Here Are 25 Stocks Moving Premarket ↗

November 21, 2022

Gainers EUDA Health Holdings Limited (NASDAQ: EUDA) shares rose 88.1% to $8.40 in pre-market trading after merger completed with 8i Acquisition SPAC last week.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 21, 2022

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com